Carbamazepine
FDA Approved
Contents
Description
Carbamazepine is an anticonvulsant and mood-stabilizing drug used primarily in the treatment of epilepsy and neuropathic pain. It works by reducing nerve impulses that cause seizures and pain. It has been used off-label for primary erythermalgia to reduce burning pain episodes.
Indications & Therapeutic Use
epilepsy, trigeminal neuralgia, neuropathic pain, primary erythermalgia
Global Availability (11 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Carbamazepine — GNH India
243 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Amizepin
EU
Biston
EU
CAR-POWER-200
200mgtabletIndia
CAR-POWER-200mg
200mgtabletIndia
Carba Retard
EU
Carbadura
EU
Carbadura Retard
EU
Carbagen
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Carbamazepine
| Generic Name | carbamazepine |
| Brands | 1 brand available |
| Active Ingredient | carbamazepine |
| Drug Class | epilepsy |
| Manufacturer | Novartis |
| Dosage Forms | oral tablet 200mg, 400mg; extended-release tablet; oral suspension 100mg/5mL |
| Medical Code | N03AF01 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved |
| Countries | 11 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations12 Validated Nodes